Immune checkpoint catalytic receptors
Immune checkpoints play a critical role in preventing autoimmunity and maintaining self-tolerance, but they can also be exploited by cancer cells to evade the immune system. There are several different types of immune checkpoints, including CTLA-4, PD-1, and LAG-3. In recent years, drugs that target these checkpoints have been developed as a new class of cancer immunotherapy.
- Iscalimab (anti-CD40)
Specifications & Purity: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC)
CAS No.: 2031153-61-2
Starting at $89.90